Dastmalchi, F., Karachi, A., Khattri, R., Merritt, M. E., Mitchell, D., & Rahman, M. (2017). METB-02. A SENSITIVE METABOLIC SIGNATURE TO PREDICT IMMUNE RESPONSE AFTER IMMUNOTHERAPY FOR BRAIN TUMORS. Neuro Oncol.
Παραπομπή Chicago StyleDastmalchi, Farhad, Aida Karachi, Ram Khattri, Matthew E. Merritt, Duane Mitchell, και Maryam Rahman. "METB-02. A SENSITIVE METABOLIC SIGNATURE TO PREDICT IMMUNE RESPONSE AFTER IMMUNOTHERAPY FOR BRAIN TUMORS." Neuro Oncol 2017.
Παραπομπή MLADastmalchi, Farhad, et al. "METB-02. A SENSITIVE METABOLIC SIGNATURE TO PREDICT IMMUNE RESPONSE AFTER IMMUNOTHERAPY FOR BRAIN TUMORS." Neuro Oncol 2017.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.